BridgeBio Pharma, Inc. (BBIO)

68.31 +0.40 (+0.59%) USD  |  NASDAQ  |  Feb 24, 16:00
70.52 +2.21 (+3.24%) Pre-Market: 09:11
More

BridgeBio Pharma Price Target Upside (Daily)

Price Target Upside (Daily) Chart

View Price Target Upside (Daily) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Upside (Daily) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Upside (Daily) Range, Past 5 Years

View Price Target Upside (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Upside (Daily) Benchmarks

View Price Target Upside (Daily) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade